Clinical trial

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

NCT00152932

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Dorzolamide 2% drops Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention HRF and CLBF Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2005-05-01

PhaseNA

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

Dorzolamide 2% dropsDRUG

HRF and CLBFDEVICE

Sponsors & collaborators

University Health Network, Torontolead sponsor

Merck Frosst Canada Ltd.collaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00152932 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.